Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Jacobs

Showing results (71-80 of 258) with videos related to

Pageof 26
Sort By:
The Journal of Antimicrobial Chemotherapy|April 17, 2003
Impact of antimicrobial resistance on health outcomes in the out-patient treatment of adult community-acquired pneumonia: a probability modelMendel E Singer, Ian Harding, Michael R Jacobs, et al.
The Journal of Antimicrobial Chemotherapy|July 17, 2003
The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agentsMichael R Jacobs, David Felmingham, Peter C Appelbaum, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2008
Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccineMichael R Jacobs, Caryn E Good, Saralee Bajaksouzian, et al.
Journal of Clinical Microbiology|February 19, 2010
Validation of factor 6d antiserum for serotyping Streptococcus pneumoniae serotype 6CMichael R Jacobs, Ron Dagan, Saralee Bajaksouzian, et al.
The Journal of Antimicrobial Chemotherapy|October 31, 2003
Contribution of beta-lactamase and PBP amino acid substitutions to amoxicillin/clavulanate resistance in beta-lactamase-positive, amoxicillin/clavulanate-resistant Haemophilus influenzaeVlatka Matic, Bülent Bozdogan, Michael R Jacobs, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2002
Activities of HMR 3787 and RU 64399 compared with those of four other agents against Haemophilus influenzae and Haemophilus parainfluenzaeBülent Bozdogan, Catherine Clark, Andre Bryskier, et al.
JAMA|March 21, 2002
First-line vs second-line antibiotics for treatment of sinusitisJack B Anon, Michael R Jacobs, Michael D Poole, et al.
Transfusion|January 22, 2005
Evaluation of the Scansystem method for detection of bacterially contaminated plateletsMichael R Jacobs, Saralee Bajaksouzian, Anne Windau, et al.
Antimicrobial Agents and Chemotherapy|December 26, 2001
Antipneumococcal activity of ertapenem (MK-0826) compared to those of other agentsGlenn A Pankuch, Todd A Davies, Michael R Jacobs, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2008
Relationship between bacterial load, species virulence, and transfusion reaction with transfusion of bacterially contaminated plateletsMichael R Jacobs, Caryn E Good, Hillard M Lazarus, et al.
Pageof 26

Showing results (71-80 of 258) with videos related to

Sort By:
Pageof 26
The Journal of Antimicrobial Chemotherapy|April 17, 2003
Impact of antimicrobial resistance on health outcomes in the out-patient treatment of adult community-acquired pneumonia: a probability modelMendel E Singer, Ian Harding, Michael R Jacobs, et al.
The Journal of Antimicrobial Chemotherapy|July 17, 2003
The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agentsMichael R Jacobs, David Felmingham, Peter C Appelbaum, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2008
Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccineMichael R Jacobs, Caryn E Good, Saralee Bajaksouzian, et al.
Journal of Clinical Microbiology|February 19, 2010
Validation of factor 6d antiserum for serotyping Streptococcus pneumoniae serotype 6CMichael R Jacobs, Ron Dagan, Saralee Bajaksouzian, et al.
The Journal of Antimicrobial Chemotherapy|October 31, 2003
Contribution of beta-lactamase and PBP amino acid substitutions to amoxicillin/clavulanate resistance in beta-lactamase-positive, amoxicillin/clavulanate-resistant Haemophilus influenzaeVlatka Matic, Bülent Bozdogan, Michael R Jacobs, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2002
Activities of HMR 3787 and RU 64399 compared with those of four other agents against Haemophilus influenzae and Haemophilus parainfluenzaeBülent Bozdogan, Catherine Clark, Andre Bryskier, et al.
JAMA|March 21, 2002
First-line vs second-line antibiotics for treatment of sinusitisJack B Anon, Michael R Jacobs, Michael D Poole, et al.
Transfusion|January 22, 2005
Evaluation of the Scansystem method for detection of bacterially contaminated plateletsMichael R Jacobs, Saralee Bajaksouzian, Anne Windau, et al.
Antimicrobial Agents and Chemotherapy|December 26, 2001
Antipneumococcal activity of ertapenem (MK-0826) compared to those of other agentsGlenn A Pankuch, Todd A Davies, Michael R Jacobs, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2008
Relationship between bacterial load, species virulence, and transfusion reaction with transfusion of bacterially contaminated plateletsMichael R Jacobs, Caryn E Good, Hillard M Lazarus, et al.
Pageof 26